Susoctocog Alfa
Products Susoctocog alfa is commercially available as a powder and solvent for solution for injection (Obizur). It was approved in the United States in 2014, in the EU in 2015, and in many countries in 2016. Structure and properties Susoctocog alfa is a recombinant derivative of porcine blood clotting factor VIII lacking the B domain. … Susoctocog Alfa